Stoke Therapeutics, Inc. · NASDAQ:STOK
Wellington Management Group LLP reported a 5.20% stake in Stoke Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed May 15, 2026
Wellington Management Group LLP reported a 5.20% stake in Stoke Therapeutics, Inc., 3,095,700 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).
- Stake
- 5.20%
- Shares
- 3,095,700
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Wellington Management Group LLP | 5.20% | 3,095,700 |
| Wellington Group Holdings LLP | 5.20% | 3,095,700 |
| Wellington Investment Advisors Holdings LLP | 5.20% | 3,095,700 |
| Wellington Management Company LLP | 5.10% | 3,095,700 |